4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-25-309636
Chief Commercial Officer sold 144 shares at $20.72 ($2,984)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Dyne Therapeutics, Inc. Filed Acc 0001193125-25-309636
Chief Commercial Officer sold 144 shares at $20.72 ($2,984)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…